The BRCAlert: Oneinforty's May 2018 eNewsletter

May 2018, Issue 4

DONATE

The BRCAlert

This issue of The BRCAlert features our May 23rd symposium details, coverage in The Jewish Advocate and a special opportunity to get fabulous while supporting Oneinforty.

Oneinforty's Spring Symposium

Wednesday, May 23rd, 2018

Temple Beth Elohim, Wellesley, MA

Symposium Panelists Include:

Amy H. Comander, MD

Medical Director, Auerbach Breast Center

Newton-Wellesley Hospital

Whitfield B. Growdon, MD

Gynecological Oncologist

Massachusetts General Hospital

Kimberly DeLeonardis, MS, CGC

Genetic Counselor

Beth Israel Deaconess

Medical Center

Camila Gabriel, MS

Sr. Research Project Manager

The BFOR Study

Dana-Farber Cancer Institute

Debbi Shamon, LICSW

Social Worker

In private practice

in Boston, MA

Oneinforty's spring symposium, Knowledge is Empowering: Understanding the Jewish - Cancer Connection, will take place on Wednesday, May 23rd at 7:00 p.m. at Temple Beth Elohim in Wellesley, Massachusetts. Leading medical professionals affiliated with Massachusetts General Hospital , Dana-Farber , Beth Israel Deaconess Medical Center and Newton-Wellesley Hospital will discuss:

"Genetics 101" regarding BRCA gene mutations
The genetic counseling and testing process
Options for genetic counseling and screening including the new BFOR Study
Resources for BRCA-positive individuals and their families
Some medical reasons to consider genetic counseling and screening

Individuals who have a BRCA gene mutation will share their moving "I am Oneinforty" stories and describe how knowing their BRCA-positive status helps them manage their cancer risk in partnership with their health care providers. There will be a Q&A session and nonprofits including Sharsheret and FORCE will exhibit.

May 16, 2018

Oneinforty promotes cancer awareness among Ashkenazi Jews

by Judy Manelis

Discovery of a BRCA gene mutation, which often leads among women to breast cancer, suggests prophylactic mastectomies. At the very least, they suggest aggressive oversight and vigilance with annual breast MRIs starting at age 25, and annual mammograms starting at age 30.

In the case of ovarian cancer, the risks are even greater, since there are few, if any, overt symptoms of ovarian cancer and no effective screening for the disease at present. A late diagnosis is the norm rather than the exception. Moreover, the time of diagnosis can be the difference between life and death.

“Why,” Bob Cooperstein asks, “didn’t any of my daughter’s doctors refer her to a genetic counselor? The information on BRCA mutations and the risk to Ashkenazi Jews was available for so many years.”

Read the full article

Get Fabulous at HC Studio While Supporting Oneinforty!

HC Studio , a lovely full-service hair salon located in Brookline, Massachusetts, is generously donating 10% of all retail and treatment sales to Oneinforty this month.

‌

Oneinforty | 617-823-3630 | laurenc@oneinforty.org | www.oneinforty.org